Delphi Diagnostics
delphi-diagnostics.com
Actively hiring
Diagnostic Tests & IVD
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
GEICAM, UNICANCER AND DELPHI DIAGNOSTICS DRIVE A JOINT ANALYSIS TO PERSONALIZE ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER
Press Release GEICAM, Unicancer and Delphi Diagnostics Drive a Joint Analysis to Personalize Adjuvant Chemotherapy in Early Breast Cancer The project will combine data from two key clinical trials to assess the value of the SET2,3 assay in HR+/HER2 breast
Read more
Report
Delphi Diagnostics Announces New Publication Confirming EAI Predicts Benefit from Weekly Paclitaxel in HR+/HER2 Breast Cancer
Delphi Diagnostics today announced the publication of findings from the GEICAM/9906 clinical trial demonstrating that the company
Read more
Report
Delphi Diagnostics Announces New Publication Confirming EAI Predicts Benefit from Weekly Paclitaxel in HR+/HER2 Breast Cancer
Press Release Delphi Diagnostics Announces New Publication Confirming EAI Predicts Benefit from Weekly Paclitaxel in HR+/HER2 Breast Cancer This analysis independently validated previous findings and further helps to establish EAI as the first genomic ass
Read more
Report
Delphi Diagnostics Announces New Publication Confirming EAI Predicts Benefit from Weekly Paclitaxel in HR+/HER2? Breast Cancer
Read more
Report
Delphi Diagnostics Appoints Eric Lindquist as Chief Financial Officer
/PRNewswire/ -- Delphi Diagnostics today announced the appointment of Eric Lindquist as Chief Financial Officer, effective April 1, 2026. Mr. Lindquist brings...
Read more
Report
Delphi Diagnostics Appoints Eric Lindquist as Chief Financial Officer
Press Release Delphi Diagnostics Appoints Eric Lindquist as Chief Financial Officer Experienced oncology and life sciences executive to lead financial strategy and support the next phase of growthA PDF of the release can be found hereMay 19, 2026, Houston
Read more
Report
Delphi Diagnostics Announces New Publication in the European Journal of Cancer
Delphi Diagnostics today announced the publication of new clinical data in the European Journal of Cancer validating EAIRR, as a significant independent predictor of outcomes in patients with hormone receptor-positive, node-positive breast cancer. The pub
Read more
Report
Delphi Diagnostics Announces New Publication in the European Journal of Cancer
Press Release Delphi Diagnostics Announces New Publication in the European Journal of Cancer Peer-reviewed manuscript demonstrates the Endocrine Activity IndexTM Recurrence Risk (EAIRR) enhances risk stratification beyond Recurrence Score and is predictiv
Read more
Report
Show more news